Vaxart, Inc.·4

Aug 22, 6:06 PM ET

Yedid Robert A. 4

4 · Vaxart, Inc. · Filed Aug 22, 2022

Insider Transaction Report

Form 4
Period: 2022-08-19
Transactions
  • Exercise/Conversion

    Stock Option (right to buy)

    2022-08-1918,24018,240 total
    Exercise: $0.31Exp: 2029-11-17Common Stock (18,240 underlying)
  • Exercise/Conversion

    Stock Option (right to buy)

    2022-08-198,00057,700 total
    Exercise: $2.39Exp: 2030-06-07Common Stock (8,000 underlying)
  • Exercise/Conversion

    Common Stock

    2022-08-19$0.31/sh+18,240$5,65429,355 total
  • Exercise/Conversion

    Common Stock

    2022-08-19$2.39/sh+8,000$19,12037,355 total
Holdings
  • Common Stock

    (indirect: By Spouse)
    1,500
Footnotes (2)
  • [F1]The shares subject to this option vest annually over three years from the vesting commencement date of October 25, 2019, the date of the grantee's appointment as a director of Vaxart, Inc.
  • [F2]The option is fully vested.

Documents

2 files